The Enterprise Value as of December 2025 (TTM) for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) is 16.32B

According to Shenzhen Hepalink Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.32B. This represents a change of -7.58% compared to the average of 17.65B of the last 4 quarters.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) Historical Enterprise Value (quarterly & annually)

How has SHEZF Enterprise Value performed in the past?

The mean historical Enterprise Value of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. over the last ten years is 24.36B. The current 16.32B Enterprise Value has changed 6.60% with respect to the historical average. Over the past ten years (40 quarters), SHEZF's Enterprise Value was at its highest in in the June 2020 quarter at 36.78B. The Enterprise Value was at its lowest in in the June 2024 quarter at 15.06B.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) Average Enterprise Value

How has SHEZF Enterprise Value performed in the past?

The current Enterprise Value of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) Enterprise Value vs. Peers

How is SHEZF’s Enterprise Value compared to its peers?

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.’s Enterprise Value is less than The United Laboratories International Holdings Limited (19.25B), less than Aspen Pharmacare Holdings Limited (71.61B), less than Aspen Pharmacare Holdings Limited (71.61B), less than Santen Pharmaceutical Co., Ltd. (474.85B), less than Livzon Pharmaceutical Group Inc. (26.54B), less than Hypera S.A. (24.56B), less than Sumitomo Pharma Co., Ltd. (1.26T), less than Sumitomo Pharma Co., Ltd. (1.26T), greater than Ansell Limited (4.04B), less than Shandong Weigao Group Medical Polymer Company Limited (19.02B),

Build a custom stock screener for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shenzhen Hepalink Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shenzhen Hepalink Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.